Key Points
- Glas fruit vapes authorized;
- No added cessation benefit shown;
- Age-gating drove approval;
- FDA standards questioned;
- Lawmakers seek explanations.
2Firsts
June 12, 2026 — The U.S. Food and Drug Administration’s recent authorization of two fruit-flavored vaping products from Glas is drawing renewed scrutiny after newly released agency documents showed the products failed to demonstrate superior smoking-cessation benefits compared with tobacco-flavored alternatives.
In May, the FDA authorized Glas mango- and blueberry-flavored vape pods, making them the first fruit-flavored vaping products to receive federal marketing authorization in the United States.
For years, the FDA has maintained that fruit and sweet flavors pose heightened youth-attraction risks and therefore must demonstrate additional public-health benefits compared with tobacco-flavored products.
However, according to a six-page FDA memorandum released this week, Glas did not meet that evidentiary threshold.
The agency stated that the data “did not demonstrate statistically significant differences” between the fruit-flavored products and tobacco-flavored e-cigarettes in helping adult smokers completely switch or substantially reduce cigarette consumption.
The FDA said Glas conducted a three-month randomized actual-use study involving adult smokers aged 22 to 64 who smoked more than 10 cigarettes per day.
Across all five flavors evaluated—including tobacco, mango, blueberry and two menthol varieties—complete switching rates ranged from 12% to 18%.
The agency noted that these rates exceeded published smoking-cessation rates of less than 6% among smokers attempting to quit without support.
Nevertheless, the fruit-flavored products failed to demonstrate any additional benefit relative to tobacco-flavored products.
Instead, the FDA’s authorization relied heavily on Glas’ age-verification technology, which regulators believe can significantly reduce youth access to flavored vaping products.
The system requires users to download a smartphone application and verify their identity and age using government-issued identification before the device can be activated. The device also locks automatically if it loses connection with the verified smartphone for a specified period.
According to FDA-reviewed studies, none of the 43 participants under age 21 successfully activated the device, while 83% to 96% of 120 adult participants completed the verification process successfully.
Based on those findings, the FDA concluded that Glas’ access-restriction technology could sufficiently mitigate youth-use risks, eliminating the need for the flavored products to demonstrate added adult benefit relative to tobacco-flavored ENDS.
That rationale differs from the evidentiary approach applied to previously authorized flavored products.
Earlier approvals for menthol products from Juul and NJOY included evidence showing greater effectiveness in helping adult smokers reduce or quit cigarette use compared with tobacco-flavored products.
By contrast, Glas’ authorization relied more heavily on technological youth-protection measures.
The memo also acknowledged that approximately 88% of youth e-cigarette users consume flavored products, with fruit flavors among the most popular categories.
As a result, flavored vaping products remain a central focus of youth-protection policies.
The FDA said Glas will be subject to ongoing post-market surveillance, along with restrictions on advertising, promotion and sales practices.
According to the Associated Press, the newly released memo is likely to intensify debate over the agency’s decision.
Ten Democratic senators previously sent a letter to the FDA seeking an explanation for the authorization and described the decision as “shortsighted and reckless.”
Several public-health organizations have also criticized the agency for changing course after years of emphasizing youth risks associated with flavored vaping products.
The FDA, however, maintains that the products satisfy the statutory standard of being “Appropriate for the Protection of the Public Health” (APPH).
The agency concluded that the products present substantially lower health risks than combustible cigarettes and may help some adult smokers transition away from smoking.
As the FDA enters a new phase of flavored-vape regulation, balancing adult harm-reduction objectives against youth-protection concerns is likely to remain a central policy challenge.
Cover image:AP Photo
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
